The creative psychosocial genomic healing experience (CPGHE) and gene expression in breast cancer patients: A feasibility study

Francisco V. Muñoz, Linda Larkey

Research output: Contribution to journalArticle

1 Citation (Scopus)

Abstract

Background: Biomarkers associated with inflammation and immune function are increasingly being used to examine mechanisms of the effects of mind-body therapies. Less researched are biomarkers associated with cognitive and executive functioning in the study of mind-body therapy mechanisms and effects. This study explored the feasibility of recruiting breast cancer patients (BCPs) and implementation fidelity of participation in a research project utilizing the 4-stage Creative Psychosocial Genomic Healing Experience (CPGHE), a mind-body protocol that is theorized to create epigenetic effects via targeted psychological change in emotional triggers in coping with cancer. Methods: Eight BCPs were identified as eligible (stages I, II, III, early phases of treatment) and five consented to one of two intervention groups (allocated to a single session or two sessions of CPGHE). Blood draws were examined pre- and post-intervention for a stress/inflammation gene expression marker, Nuclear Factor kappa-B (NF-kB), and three markers associated with synaptic plasticity undergirding cognitive and executive functioning: Early Growth Response 1 (EGR1), activity-regulated cytoskeleton-associated protein (Arc), and brain-derived neurotrophic factor (BDNF). Results: One consented BCP dropped out due to illness. The remaining four adhered to the 4-stage CPGHE protocol and found the CPGHE experience beneficial. Blood samples for the gene expression results were collected and processed according to planned protocol without incident. Conclusion: Implementing the CPGHE and achieving good adherence among a sample of BCPs is feasible. Processing of blood samples collected from BCPs for gene expression data is also feasible.

Original languageEnglish (US)
JournalAdvances in Integrative Medicine
DOIs
StateAccepted/In press - Jan 1 2018

Fingerprint

Feasibility Studies
Breast Neoplasms
Gene Expression
Mind-Body Therapies
Biomarkers
Inflammation
Neuronal Plasticity
NF-kappa B
Neoplasm Genes
Brain-Derived Neurotrophic Factor
Cytoskeleton
Epigenomics
Psychology
Growth
Research
Neoplasms
Proteins

Keywords

  • Arc gene expression
  • BDNF gene expression
  • Breast cancer
  • EGR1 (zif-268) gene expression
  • Mind-body therapy
  • NF-kB gene expression
  • Stress

ASJC Scopus subject areas

  • Complementary and alternative medicine

Cite this

@article{ebec161031af44f69c1a2762085f9533,
title = "The creative psychosocial genomic healing experience (CPGHE) and gene expression in breast cancer patients: A feasibility study",
abstract = "Background: Biomarkers associated with inflammation and immune function are increasingly being used to examine mechanisms of the effects of mind-body therapies. Less researched are biomarkers associated with cognitive and executive functioning in the study of mind-body therapy mechanisms and effects. This study explored the feasibility of recruiting breast cancer patients (BCPs) and implementation fidelity of participation in a research project utilizing the 4-stage Creative Psychosocial Genomic Healing Experience (CPGHE), a mind-body protocol that is theorized to create epigenetic effects via targeted psychological change in emotional triggers in coping with cancer. Methods: Eight BCPs were identified as eligible (stages I, II, III, early phases of treatment) and five consented to one of two intervention groups (allocated to a single session or two sessions of CPGHE). Blood draws were examined pre- and post-intervention for a stress/inflammation gene expression marker, Nuclear Factor kappa-B (NF-kB), and three markers associated with synaptic plasticity undergirding cognitive and executive functioning: Early Growth Response 1 (EGR1), activity-regulated cytoskeleton-associated protein (Arc), and brain-derived neurotrophic factor (BDNF). Results: One consented BCP dropped out due to illness. The remaining four adhered to the 4-stage CPGHE protocol and found the CPGHE experience beneficial. Blood samples for the gene expression results were collected and processed according to planned protocol without incident. Conclusion: Implementing the CPGHE and achieving good adherence among a sample of BCPs is feasible. Processing of blood samples collected from BCPs for gene expression data is also feasible.",
keywords = "Arc gene expression, BDNF gene expression, Breast cancer, EGR1 (zif-268) gene expression, Mind-body therapy, NF-kB gene expression, Stress",
author = "Mu{\~n}oz, {Francisco V.} and Linda Larkey",
year = "2018",
month = "1",
day = "1",
doi = "10.1016/j.aimed.2018.03.001",
language = "English (US)",
journal = "Advances in Integrative Medicine",
issn = "2212-9588",
publisher = "Elsevier BV",

}

TY - JOUR

T1 - The creative psychosocial genomic healing experience (CPGHE) and gene expression in breast cancer patients

T2 - A feasibility study

AU - Muñoz, Francisco V.

AU - Larkey, Linda

PY - 2018/1/1

Y1 - 2018/1/1

N2 - Background: Biomarkers associated with inflammation and immune function are increasingly being used to examine mechanisms of the effects of mind-body therapies. Less researched are biomarkers associated with cognitive and executive functioning in the study of mind-body therapy mechanisms and effects. This study explored the feasibility of recruiting breast cancer patients (BCPs) and implementation fidelity of participation in a research project utilizing the 4-stage Creative Psychosocial Genomic Healing Experience (CPGHE), a mind-body protocol that is theorized to create epigenetic effects via targeted psychological change in emotional triggers in coping with cancer. Methods: Eight BCPs were identified as eligible (stages I, II, III, early phases of treatment) and five consented to one of two intervention groups (allocated to a single session or two sessions of CPGHE). Blood draws were examined pre- and post-intervention for a stress/inflammation gene expression marker, Nuclear Factor kappa-B (NF-kB), and three markers associated with synaptic plasticity undergirding cognitive and executive functioning: Early Growth Response 1 (EGR1), activity-regulated cytoskeleton-associated protein (Arc), and brain-derived neurotrophic factor (BDNF). Results: One consented BCP dropped out due to illness. The remaining four adhered to the 4-stage CPGHE protocol and found the CPGHE experience beneficial. Blood samples for the gene expression results were collected and processed according to planned protocol without incident. Conclusion: Implementing the CPGHE and achieving good adherence among a sample of BCPs is feasible. Processing of blood samples collected from BCPs for gene expression data is also feasible.

AB - Background: Biomarkers associated with inflammation and immune function are increasingly being used to examine mechanisms of the effects of mind-body therapies. Less researched are biomarkers associated with cognitive and executive functioning in the study of mind-body therapy mechanisms and effects. This study explored the feasibility of recruiting breast cancer patients (BCPs) and implementation fidelity of participation in a research project utilizing the 4-stage Creative Psychosocial Genomic Healing Experience (CPGHE), a mind-body protocol that is theorized to create epigenetic effects via targeted psychological change in emotional triggers in coping with cancer. Methods: Eight BCPs were identified as eligible (stages I, II, III, early phases of treatment) and five consented to one of two intervention groups (allocated to a single session or two sessions of CPGHE). Blood draws were examined pre- and post-intervention for a stress/inflammation gene expression marker, Nuclear Factor kappa-B (NF-kB), and three markers associated with synaptic plasticity undergirding cognitive and executive functioning: Early Growth Response 1 (EGR1), activity-regulated cytoskeleton-associated protein (Arc), and brain-derived neurotrophic factor (BDNF). Results: One consented BCP dropped out due to illness. The remaining four adhered to the 4-stage CPGHE protocol and found the CPGHE experience beneficial. Blood samples for the gene expression results were collected and processed according to planned protocol without incident. Conclusion: Implementing the CPGHE and achieving good adherence among a sample of BCPs is feasible. Processing of blood samples collected from BCPs for gene expression data is also feasible.

KW - Arc gene expression

KW - BDNF gene expression

KW - Breast cancer

KW - EGR1 (zif-268) gene expression

KW - Mind-body therapy

KW - NF-kB gene expression

KW - Stress

UR - http://www.scopus.com/inward/record.url?scp=85044863988&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85044863988&partnerID=8YFLogxK

U2 - 10.1016/j.aimed.2018.03.001

DO - 10.1016/j.aimed.2018.03.001

M3 - Article

AN - SCOPUS:85044863988

JO - Advances in Integrative Medicine

JF - Advances in Integrative Medicine

SN - 2212-9588

ER -